---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-227949"
form_type: "8-K"
ticker: "BIOA"
cik: "0001709941"
company_name: "BioAge Labs, Inc."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:12:07.176829+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# BioAge Labs sells 588,888 shares to Sofinnova at $18 in private placement concurrent with IPO

## Summary
- Private placement of 588,888 shares to existing stockholder Sofinnova at IPO price of $18.00/share, raising $10.6 million.
- Placement agents Goldman Sachs, Morgan Stanley, Jefferies, Citigroup received 7.0% fee on total purchase price.
- Shares unregistered, issued under Section 4(a)(2) to an institutional accredited investor; registration rights after one year if not saleable under Rule 144.
- Closing occurred on September 27, 2024, concurrently with the IPO closing.

## SEC filing metadata
- accession: 0001193125-24-227949
- form_type: 8-K
- ticker: BIOA
- cik: 0001709941
- company_name: BioAge Labs, Inc.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1709941/000119312524227949/0001193125-24-227949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1709941/000119312524227949/d890673d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-227949
- JSON: https://secwatch.observer/filing/0001193125-24-227949.json
- Plain text: https://secwatch.observer/filing/0001193125-24-227949.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.